Rana R. McKay

This study shows that inhibiting PIM kinases in tumor-associated macrophages reduces inflammasome activation and improves response to immunotherapy in prostate cancer.

The authors reanalyze their pan-cancer microbiome findings using decontaminated data to address concerns about contamination, batch effects, and machine learning approaches.